Figure (Tizanidine Tabs 8468 8469 1)
Tizanidine Tablet
Product Images NDC 0615-8469
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 0615-8469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Tizanidine Tabs 8468 8469 2)
Figure (Tizanidine Tabs 8468 8469 3)
Figure (Tizanidine Tabs 8468 8469 4)
This text describes the results of a study evaluating the effectiveness of tizanidine in reducing the Ashworth Score. The mean dose was 26.8 mg and the study lasted for 7 weeks, with the endpoint being the last observation carried forward. The study observed improvements in Ashworth Score with tizanidine.*
Principal Display Panel (Tizanidine Tabs 8468 8469 5)
This appears to be a document related to the medication Tizanidine Tab USP 2 mg. The document includes lot numbers and expiration dates for the medication, as well as information on the manufacturer and packaging. Additionally, there are instructions for storage and dispensing of the medication.*
Principal Display Panel (Tizanidine Tabs 8468 8469 6)
This is a pharmaceutical label for Tizanidine Tablets. The tablets contain 4 mg of Tizanidine and are not interchangeable with Tizanidine capsules. The lot number, expiry date, and dosage instructions are provided on the label.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
